From What’s Hot in Boston Biotech: The Photos:

What's Hot in Boston Biotech
What’s Hot in Boston Biotech

One of the points Vertex Pharmaceuticals’s David Altshuler (right) made is that many of the clinical failures of the past decade weren’t an indictment of genomics—they were projects from the 90s, before the Human Genome Project. “Go look at what those projects were. What were they based upon? What was the logic? They were from a previous era,” he said.